Stock·NASDAQ·Technology
Sunrun Inc. (RUN)
- Market cap
- $1.74B
- P/E
- 4.93
- Dividend yield
- 0.00%
- Street target
- $14.00median of 20 analysts
- 52-week range
- $7.17 $21.95
The short version
Where RUN stands today, in four lines, and what CleaRank Financial AI makes of it.
RUN at a glance
Sunrun Inc. (RUN): Hold, 47/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($8.60 and $12.97).
- Insiders Insiders sold $29.4M and bought $693K over the last 18 months.
- Valuation P/E of 4.9 against 35.1 for the Technology sector: a discount to peers (-86%).
Figures as of October 18, 2026.
CleaRank Financial AI
Sunrun Inc. (RUN) receives a Hold rating from CleaRank, with a model score of 47/100.
The biggest contributor to that score is valuation: the P/E of 4.93 is 85.9% below the sector median, a discount to peers, and the P/S of 0.50 is 93.4% below the sector median. The trend is the largest drag. The price sits 43.72% below the 200-day average and 15.08% below the 50-day, and the 50-day is 33.72% below the 200-day. The 50-day average is $8.60 and the 200-day is $12.97. The price fell 63.75% over the past year.
Only on CleaRank
Figures we compute ourselves from RUN's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $7.30 is 15.1% below the 50-day simple moving average of $8.60.Price above its 200-day average ›
The price is 43.7% below the 200-day simple moving average of $12.97.50-day average above the 200-day ›
The 50-day average ($8.60) is 33.7% below the 200-day average ($12.97), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $7.17 and $21.95.
RUN share price
Pick a period: each tab shows how far RUN has moved over it, to the last close.
Today's trading
Where RUN sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/3P/E below the sector median ›
The trailing P/E of 4.93 is 85.9% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 0.50 is 93.4% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $400.7M on revenue of $3.5B, a net margin of 11.5%.
Key statistics
The headline figures for RUN.
As of October 18, 2026, RUN trades at $7.30, with a market value of $1.74B and a P/E ratio of 4.93.
What the numbers say
CleaRank Financial AI's reading of RUN's valuation, growth and risks.
RUN's trailing P/E of 4.93 is 85.9% below the Technology median of 35.1, a gap the peer comparison on this page labels a discount to peers. On sales, the P/S of 0.50 is 93.4% below the sector median of 7.6.
Revenue grew 52.80% over the latest year, which is 28.6 percentage points ahead of the 24.2% median for Technology. RUN turns sales into profit at a net margin of 11.59% and an operating margin of 4.00%, alongside a return on equity of -19.86%, below the sector median of 13.4%. It also reports debt-to-equity of 2.93.
The consensus EPS estimate stands at $1.41 for this fiscal year and $0.6531 for next, a decline of 17.4% for the current year.
On a typical day the price of RUN shifts by 3.25%, the 30-day standard deviation of its daily returns. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 66.74% below its 52-week high of $21.95. Over the last 18 months, insider sales totalled $29.4M against $693K of purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
RUN against the Technology sector
How RUN compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: RUN trades at a notable discount to sector peers (-86%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 6, 2025, RUN has gained 3.4% against a gain of 71.7% for XLK.
Performance against XLK
RUN and the Technology sector fund over the same days.
Revenue and earnings
How much RUN sells, and how much of it becomes profit.
Revenue growth: Revenue grew 45.1% in FY2025 to $3.0B, from $2.0B a year earlier.
Profit margin: The net margin was -34.1% in FY2025, up from -213.7% the year before.
Loss-making: RUN lost $1.0B in FY2025.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 37.9, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 37.9 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of RUN
The score, the reasoning behind it, and what could move the price next.
Sunrun Inc. (RUN) changed hands at $7.30 and sits under both of its main moving averages. The price is 15.08% below the 50-day average of $8.60 and 43.72% below the 200-day average of $12.97. It sits at 1% of its 52-week range, with the price 1.81% above the 52-week low of $7.17. The 50-day average is 33.72% below the 200-day, so the two averages point the same way.
On momentum, the 14-day RSI reads 37.9, in the bearish zone, above the oversold line, with the MACD line negative. Every period on the chart shows a loss, with the price down 38.40% over the past three months, 41.13% over the past six months and 63.75% over the past year.
Rating reaffirmed ›
Citigroup kept its Buy rating on October 9, 2026.
Source: Analyst action, Citigroup, October 9, 2026
No risks flagged.
- The two levels closest to the price matter most. Above it, the 20-day EMA at $7.82. Below it, the 52-week low at $7.17.
- The 14-day RSI reads 37.9, in the bearish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
RUN stays in a downtrend for as long as it trades below both its 50-day average at $8.60 and its 200-day average at $12.97. A close back above the 50-day would be the first sign of a repair. The 20-day EMA, at $7.82, is the first hurdle above the price.
The next level below the price is the 52-week low at $7.17.
Technical indicators
Momentum and trend for RUN, from its daily closes.
As of October 18, 2026, with RUN at $7.30, its 14-day RSI is 37.9 (showing bearish momentum without being oversold), its 50-day simple moving average is $8.60 and its 200-day is $12.97.
Calculated by CleaRank on daily closes as of October 18, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What RUN moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 18, 2026, RUN's 1-year correlation of daily returns is +0.26 with S&P 500 (SPY), +0.26 with Nasdaq 100 (QQQ), +0.25 with Bitcoin (BTC) and +0.12 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
11 of 20 analysts rate it a buy or strong buy, 9 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $14.00 is 91.8% above the price.More buy ratings than three months ago ›
11 of 20 rate it a buy now, against 12 of 22 three months ago.
RUN Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Citigroup | Maintains | Buy |
| Oct 9, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 8, 2026 | Goldman Sachs | Maintains | Buy |
| Sep 21, 2026 | Goldman Sachs | Maintains | Buy |
| Aug 17, 2026 | GLJ Research | Reiterates | Sell |
| Aug 14, 2026 | Wells Fargo | Maintains | Overweight |
As of October 18, 2026, 20 Wall Street analysts cover RUN: 11 rate it a buy or strong buy, 9 a hold and 0 a sell or strong sell. Their 12-month price targets range from $7.00 to $30.00, with a median of $14.00, 91.8% above the price of $7.30.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
RUN trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
RUN moves about 3.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much RUN tends to move, against the market and on its own.
The long record
RUN's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.25% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 93.9%, from January 2021 to April 2025; the price is still 92.2% below that peak.Most 1-year holds ended higher ›
52% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $11,179, against $41,793 in the S&P 500 (SPY).
RUN Drawdowns & Recovery
As of October 18, 2026, RUN's worst peak-to-trough fall over the last 10 years with dividends reinvested was -93.9% (January 2021 to April 2025); it is still 92.2% below that peak, and 52% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into RUN in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: RUN trailed the S&P 500 over this period: $11,179 against $41,793.
A $10,000 investment in RUN in October 2016 would be worth about $11,179 today with dividends reinvested, compared with about $41,793 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to RUN, and which have not.
Strongest month, July: an average of +13.31%, up in 7 of 10 years.
Weakest month, March: an average of -8.27%, up in 2 of 10 years.
This month, October: has averaged -4.08%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, RUN's strongest calendar month has been July (average +13.31%, up in 7 of 10 years) and its weakest March (average -8.27%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in RUN, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in RUN today could grow to about $14,444 by 2036 in the base case, with a 90th-percentile outcome near $109,579 and a 10th-percentile outcome around $1,904. Projections are statistical simulations, not guarantees.
RUN Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $8.46 for RUN by 2030 in the base case, from $7.30 today (1.2x over 4 years). The 10th-percentile path ends near $2.35. These are outcomes of a Monte Carlo simulation run on RUN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $3.99 | $7.57 | $14.37 | |
| 2028 | $3.17 | $7.86 | $19.45 | |
| 2029 | $2.69 | $8.15 | $24.73 | |
| 2030 | $2.35 | $8.46 | $30.46 | |
| 2031 | $2.09 | $8.77 | $36.77 |
Method: a lognormal simulation of RUN's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
RUN insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $693K on the open market and sold $29.4M.
As of October 18, 2026, RUN insiders reported 83 open-market sales worth $29.4M and 2 open-market purchases worth $693K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 24.3K | $188.9K |
| Oct 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 16.7K | $129.9K |
| Oct 6, 2026 | Paul S Dickson
President
|
Sell | 15.8K | $123.0K |
| Oct 6, 2026 | Jeanna C Steele
Officer
|
Sell | 10.0K | $78.0K |
| Oct 6, 2026 | Maria Barak
Officer
|
Sell | 1.8K | $13.8K |
| Oct 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 16.8K | - |
| Aug 3, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $498.1K |
| Jul 9, 2026 | Maria Barak
Officer
|
Sell | 3.3K | $39.9K |
| Jul 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 24.0K | $316.3K |
| Jul 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 16.5K | $217.5K |
| Jul 6, 2026 | Paul S Dickson
President
|
Sell | 15.6K | $205.9K |
| Jul 6, 2026 | Jeanna C Steele
Officer
|
Sell | 9.9K | $130.5K |
| Jul 6, 2026 | Maria Barak
Officer
|
Sell | 1.7K | $23.0K |
| Jul 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 17.1K | - |
| Jul 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $680.3K |
| Jul 1, 2026 | Edward Harris Fenster
Director
|
Grant | 8.3K | - |
| Jul 1, 2026 | Lynn Michelle Jurich
Director
|
Grant | 8.3K | - |
| Jun 11, 2026 | Sonita Lontoh
Director
|
Sell | 7.5K | $90.0K |
| Jun 8, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 2.0K | $27.2K |
| Jun 8, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 2.0K | - |
| Jun 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $796.2K |
| May 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $644.5K |
| Apr 10, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 130.6K | - |
| Apr 10, 2026 | Maria Barak
Officer
|
Grant | 20.1K | - |
| Apr 10, 2026 | Paul S Dickson
President
|
Grant | 148.0K | - |
| Apr 10, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 201.2K | - |
| Apr 10, 2026 | Jeanna C Steele
Officer
|
Grant | 87.1K | - |
| Apr 9, 2026 | Maria Barak
Officer
|
Sell | 8.0K | $109.9K |
| Apr 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 193.0K | $2.6M |
| Apr 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 133.0K | $1.8M |
| Apr 6, 2026 | Paul S Dickson
President
|
Sell | 127.7K | $1.7M |
| Apr 6, 2026 | Jeanna C Steele
Officer
|
Sell | 76.5K | $1.0M |
| Apr 6, 2026 | Maria Barak
Officer
|
Sell | 4.6K | $61.5K |
| Apr 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 123.5K | - |
| Apr 1, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $703.6K |
| Mar 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 2.2K | $26.6K |
| Mar 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 1.4K | $16.9K |
| Mar 6, 2026 | Paul S Dickson
President
|
Sell | 1.1K | $13.0K |
| Mar 6, 2026 | Jeanna C Steele
Officer
|
Sell | 901 | $10.8K |
| Mar 6, 2026 | Lynn Michelle Jurich
Director
|
Sell | 450 | $5.4K |
| Mar 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 2.6K | - |
| Mar 3, 2026 | Alan D Ferber
Director
|
Buy | 12.5K | $149.0K |
| Mar 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 55.5K | $703.8K |
| Mar 2, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 5.4K | $66.1K |
| Mar 2, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 4.2K | $51.7K |
| Mar 2, 2026 | Jeanna C Steele
Officer
|
Sell | 1.1K | $13.6K |
| Mar 2, 2026 | Paul S Dickson
President
|
Sell | 1.0K | $12.6K |
| Mar 2, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 6.7K | - |
| Feb 27, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 185.3K | - |
| Feb 27, 2026 | Paul S Dickson
President
|
Grant | 197.8K | - |
| Feb 27, 2026 | Edward Harris Fenster
Director
|
Grant | 5.6K | - |
| Feb 27, 2026 | Lynn Michelle Jurich
Director
|
Grant | 12.7K | - |
| Feb 27, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 269.9K | - |
| Feb 27, 2026 | Mary G Powell
Chief Executive Officer
|
Grant | 270.6K | - |
| Feb 27, 2026 | Jeanna C Steele
Officer
|
Grant | 107.5K | - |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Sell | 163.8K | $3.3M |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Grant | 25.0K | - |
| Feb 11, 2026 | Edward Harris Fenster
Director
|
Option | 250.6K | $1.3M |
| Feb 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $929.7K |
| Jan 9, 2026 | Maria Barak
Officer
|
Sell | 1.6K | $30.2K |
| Jan 6, 2026 | Mary G Powell
Chief Executive Officer
|
Sell | 8.8K | $155.8K |
| Jan 6, 2026 | Danny Abajian
Chief Financial Officer
|
Sell | 7.2K | $128.0K |
| Jan 6, 2026 | Paul S Dickson
President
|
Sell | 6.1K | $108.9K |
| Jan 6, 2026 | Jeanna C Steele
Officer
|
Sell | 4.4K | $78.8K |
| Jan 6, 2026 | Maria Barak
Officer
|
Sell | 1.2K | $21.4K |
| Jan 6, 2026 | Danny Abajian
Chief Financial Officer
|
Grant | 10.9K | - |
| Jan 2, 2026 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $963.9K |
| Jan 2, 2026 | Katherine August-Dewilde
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Craig Cornelius
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Leslie A Dach
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Alan D Ferber
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | Sonita Lontoh
Director
|
Grant | 9.7K | - |
| Jan 2, 2026 | John Trinta
Director
|
Grant | 9.7K | - |
| Dec 22, 2025 | Edward Harris Fenster
Director
|
Sell | 32.8K | $655.7K |
| Dec 22, 2025 | Edward Harris Fenster
Director
|
Option | 50.0K | $254.0K |
| Dec 8, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 2.9K | $51.5K |
| Dec 8, 2025 | Paul S Dickson
President
|
Sell | 2.4K | $42.2K |
| Dec 8, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 2.0K | $35.7K |
| Dec 8, 2025 | Jeanna C Steele
Officer
|
Sell | 1.9K | $33.3K |
| Dec 8, 2025 | Lynn Michelle Jurich
Director
|
Sell | 451 | $8.0K |
| Dec 8, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 2.0K | - |
| Dec 5, 2025 | Edward Harris Fenster
Director
|
Sell | 133.3K | $2.4M |
| Dec 5, 2025 | Edward Harris Fenster
Director
|
Option | 200.0K | $1.0M |
| Dec 1, 2025 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $978.7K |
| Nov 13, 2025 | Maria Barak
Officer
|
Sell | 6.3K | $121.6K |
| Nov 6, 2025 | Craig Cornelius
Director
|
Grant | 1.4K | - |
| Nov 3, 2025 | Lynn Michelle Jurich
Director
|
Sell | 50.0K | $1.0M |
| Oct 15, 2025 | Jeanna C Steele
Officer
|
Sell | 4.5K | $97.1K |
| Oct 9, 2025 | Jeanna C Steele
Officer
|
Sell | 21.0K | $426.0K |
| Oct 8, 2025 | Jeanna C Steele
Officer
|
Sell | 6.0K | $116.0K |
| Oct 7, 2025 | Paul S Dickson
President
|
Sell | 20.6K | $407.4K |
| Oct 7, 2025 | Paul S Dickson
President
|
Option | 12.5K | $112.5K |
| Oct 6, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 11.7K | $226.3K |
| Oct 6, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 9.1K | $175.2K |
| Oct 6, 2025 | Maria Barak
Officer
|
Sell | 1.0K | $19.4K |
| Oct 6, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 9.0K | - |
| Oct 1, 2025 | Lynn Michelle Jurich
Director
|
Sell | 100.0K | $1.8M |
| Oct 1, 2025 | Paul S Dickson
President
|
Sell | 25.6K | $512.3K |
| Oct 1, 2025 | Jeanna C Steele
Officer
|
Sell | 20.4K | $395.2K |
| Oct 1, 2025 | Paul S Dickson
President
|
Option | 4.9K | $30.7K |
| Sep 8, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 3.1K | $53.2K |
| Sep 8, 2025 | Paul S Dickson
President
|
Sell | 2.6K | $43.6K |
| Sep 8, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 2.2K | $36.9K |
| Sep 8, 2025 | Jeanna C Steele
Officer
|
Sell | 1.4K | $24.3K |
| Sep 8, 2025 | Lynn Michelle Jurich
Director
|
Sell | 490 | $8.3K |
| Sep 8, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 1.8K | - |
| Sep 2, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 1.8K | $28.5K |
| Aug 26, 2025 | Jeanna C Steele
Officer
|
Sell | 7.1K | $118.5K |
| Aug 18, 2025 | Jeanna C Steele
Officer
|
Sell | 17.4K | $283.0K |
| Aug 13, 2025 | Alan D Ferber
Director
|
Sell | 10.9K | $122.8K |
| Jul 7, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 11.5K | $124.3K |
| Jul 7, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 8.9K | $96.3K |
| Jul 7, 2025 | Paul S Dickson
President
|
Sell | 8.0K | $86.6K |
| Jul 7, 2025 | Jeanna C Steele
Officer
|
Sell | 3.7K | $39.6K |
| Jul 7, 2025 | Maria Barak
Officer
|
Sell | 988 | $10.7K |
| Jul 7, 2025 | Danny Abajian
Chief Financial Officer
|
Grant | 9.1K | - |
| Jun 6, 2025 | Mary G Powell
Chief Executive Officer
|
Sell | 3.0K | $24.5K |
| Jun 6, 2025 | Paul S Dickson
President
|
Sell | 2.4K | $20.1K |
| Jun 6, 2025 | Danny Abajian
Chief Financial Officer
|
Sell | 1.6K | $13.2K |
| Jun 6, 2025 | Jeanna C Steele
Officer
|
Sell | 1.4K | $11.2K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 18, 2026.